questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Lipoprotéines
Apolipoprotéines
Apolipoprotéines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Apolipoprotéines
Tests de laboratoire
Apolipoprotéines
Analyse sanguine
Maladies cardiovasculaires
Apolipoprotéines
Imagerie médicale
Apolipoprotéines
Athérosclérose
Apolipoprotéines
Symptômes
5
Douleur thoracique
Apolipoprotéines
Métabolisme lipidique
Apolipoprotéines
Cholestérol
Apolipoprotéines
Accident vasculaire cérébral
Apolipoprotéines
Prévention
5
Prévention
Apolipoprotéines
Tabagisme
Apolipoprotéines
Contrôle de santé
Apolipoprotéines
Hydratation
Apolipoprotéines
Traitements
5
Statines
Apolipoprotéines
Médicaments hypolipémiants
Apolipoprotéines
Régime alimentaire
Apolipoprotéines
Exercice physique
Apolipoprotéines
Médecine complémentaire
Apolipoprotéines
Complications
5
Maladies cardiovasculaires
Apolipoprotéines
Maladies hépatiques
Apolipoprotéines
Santé rénale
Apolipoprotéines
Inflammation
Apolipoprotéines
Facteurs de risque
5
Hérédité
Apolipoprotéines
Vieillissement
Apolipoprotéines
Mode de vie sédentaire
Apolipoprotéines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines : Questions médicales les plus fréquentes",
"headline": "Apolipoprotéines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Apolipoprotéines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-26",
"dateModified": "2025-02-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lipoprotéines",
"url": "https://questionsmedicales.fr/mesh/D008074",
"about": {
"@type": "MedicalCondition",
"name": "Lipoprotéines",
"code": {
"@type": "MedicalCode",
"code": "D008074",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines M",
"alternateName": "Apolipoproteins M",
"url": "https://questionsmedicales.fr/mesh/D000075243",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines M",
"code": {
"@type": "MedicalCode",
"code": "D000075243",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines A",
"alternateName": "Apolipoproteins A",
"url": "https://questionsmedicales.fr/mesh/D001054",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines A",
"code": {
"@type": "MedicalCode",
"code": "D001054",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine A-I",
"alternateName": "Apolipoprotein A-I",
"url": "https://questionsmedicales.fr/mesh/D016632",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine A-I",
"code": {
"@type": "MedicalCode",
"code": "D016632",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.200.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine A-II",
"alternateName": "Apolipoprotein A-II",
"url": "https://questionsmedicales.fr/mesh/D016633",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine A-II",
"code": {
"@type": "MedicalCode",
"code": "D016633",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.200.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine A-V",
"alternateName": "Apolipoprotein A-V",
"url": "https://questionsmedicales.fr/mesh/D000072040",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine A-V",
"code": {
"@type": "MedicalCode",
"code": "D000072040",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.200.575"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines B",
"alternateName": "Apolipoproteins B",
"url": "https://questionsmedicales.fr/mesh/D001055",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines B",
"code": {
"@type": "MedicalCode",
"code": "D001055",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.300"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine B-48",
"alternateName": "Apolipoprotein B-48",
"url": "https://questionsmedicales.fr/mesh/D053283",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine B-48",
"code": {
"@type": "MedicalCode",
"code": "D053283",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.300.240"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine B-100",
"alternateName": "Apolipoprotein B-100",
"url": "https://questionsmedicales.fr/mesh/D053299",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine B-100",
"code": {
"@type": "MedicalCode",
"code": "D053299",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.300.249"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines C",
"alternateName": "Apolipoproteins C",
"url": "https://questionsmedicales.fr/mesh/D001056",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines C",
"code": {
"@type": "MedicalCode",
"code": "D001056",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine C-I",
"alternateName": "Apolipoprotein C-I",
"url": "https://questionsmedicales.fr/mesh/D053302",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine C-I",
"code": {
"@type": "MedicalCode",
"code": "D053302",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.400.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine C-II",
"alternateName": "Apolipoprotein C-II",
"url": "https://questionsmedicales.fr/mesh/D053304",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine C-II",
"code": {
"@type": "MedicalCode",
"code": "D053304",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.400.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine C-III",
"alternateName": "Apolipoprotein C-III",
"url": "https://questionsmedicales.fr/mesh/D053305",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine C-III",
"code": {
"@type": "MedicalCode",
"code": "D053305",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.400.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines D",
"alternateName": "Apolipoproteins D",
"url": "https://questionsmedicales.fr/mesh/D053399",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines D",
"code": {
"@type": "MedicalCode",
"code": "D053399",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines E",
"alternateName": "Apolipoproteins E",
"url": "https://questionsmedicales.fr/mesh/D001057",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines E",
"code": {
"@type": "MedicalCode",
"code": "D001057",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine E2",
"alternateName": "Apolipoprotein E2",
"url": "https://questionsmedicales.fr/mesh/D053329",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine E2",
"code": {
"@type": "MedicalCode",
"code": "D053329",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.500.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine E3",
"alternateName": "Apolipoprotein E3",
"url": "https://questionsmedicales.fr/mesh/D053318",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine E3",
"code": {
"@type": "MedicalCode",
"code": "D053318",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.500.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine E4",
"alternateName": "Apolipoprotein E4",
"url": "https://questionsmedicales.fr/mesh/D053327",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine E4",
"code": {
"@type": "MedicalCode",
"code": "D053327",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.500.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéines L",
"alternateName": "Apolipoproteins L",
"url": "https://questionsmedicales.fr/mesh/D000075943",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines L",
"code": {
"@type": "MedicalCode",
"code": "D000075943",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Apolipoprotéine L1",
"alternateName": "Apolipoprotein L1",
"url": "https://questionsmedicales.fr/mesh/D000075944",
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéine L1",
"code": {
"@type": "MedicalCode",
"code": "D000075944",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.120.750.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Apolipoprotéines",
"alternateName": "Apolipoproteins",
"code": {
"@type": "MedicalCode",
"code": "D001053",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Joan Carles Escolà-Gil",
"url": "https://questionsmedicales.fr/author/Joan%20Carles%20Escol%C3%A0-Gil",
"affiliation": {
"@type": "Organization",
"name": "Institut de Recerca Sant Pau, 08041 Barcelona, Spain."
}
},
{
"@type": "Person",
"name": "Robert A Hegele",
"url": "https://questionsmedicales.fr/author/Robert%20A%20Hegele",
"affiliation": {
"@type": "Organization",
"name": "Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Department of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Department of Medicine, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Catherine Mounier",
"url": "https://questionsmedicales.fr/author/Catherine%20Mounier",
"affiliation": {
"@type": "Organization",
"name": "Laboratoire du Métabolisme Moléculaire des Lipides, Université du Québec à Montréal, Département des Sciences Biologiques, Case Postale 8888, Succursale Centre-ville, Montréal, QC H3C 3P8, Canada."
}
},
{
"@type": "Person",
"name": "Allan Sniderman",
"url": "https://questionsmedicales.fr/author/Allan%20Sniderman",
"affiliation": {
"@type": "Organization",
"name": "Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[Leukocytoclastic vasculitis as an adverse effect of propylthiouracil. A case report].",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37566757",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.29262/ram.v70i1.1210"
}
},
{
"@type": "ScholarlyArticle",
"name": "DRESS/DiHS syndrome induced by Propylthiouracil: a case report.",
"datePublished": "2023-01-23",
"url": "https://questionsmedicales.fr/article/36691013",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12902-023-01273-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of Propylthiouracil vs Methimazole for Thyroid Storm in Critically Ill Patients.",
"datePublished": "2023-04-03",
"url": "https://questionsmedicales.fr/article/37067797",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2023.8655"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hypertrophic Pachymeningitis Associated with Myeloperoxidase-anti-neutrophil Cytoplasmic Antibodies Induced by Propylthiouracil.",
"datePublished": "2022-11-16",
"url": "https://questionsmedicales.fr/article/36384900",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2169/internalmedicine.0692-22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of the safety between propylthiouracil and methimazole with hyperthyroidism in pregnancy: A systematic review and meta-analysis.",
"datePublished": "2023-05-19",
"url": "https://questionsmedicales.fr/article/37205692",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0286097"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lipoprotéines",
"item": "https://questionsmedicales.fr/mesh/D008074"
},
{
"@type": "ListItem",
"position": 5,
"name": "Apolipoprotéines",
"item": "https://questionsmedicales.fr/mesh/D001053"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Apolipoprotéines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Apolipoprotéines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Apolipoprotéines",
"description": "Comment diagnostiquer une anomalie des apolipoprotéines ?\nQuels tests sont utilisés pour évaluer les apolipoprotéines ?\nLes apolipoprotéines sont-elles liées aux maladies cardiovasculaires ?\nPeut-on détecter des apolipoprotéines par imagerie ?\nQuels symptômes peuvent indiquer un problème d'apolipoprotéines ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Propylthiouracil#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Apolipoprotéines",
"description": "Quels symptômes sont associés à des niveaux élevés d'apolipoprotéines ?\nLes apolipoprotéines affectent-elles le métabolisme ?\nComment les apolipoprotéines influencent-elles le cholestérol ?\nDes symptômes neurologiques peuvent-ils être liés aux apolipoprotéines ?\nLes apolipoprotéines sont-elles liées à l'obésité ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Propylthiouracil#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Apolipoprotéines",
"description": "Comment prévenir les anomalies d'apolipoprotéines ?\nLe tabagisme influence-t-il les apolipoprotéines ?\nLe stress a-t-il un impact sur les apolipoprotéines ?\nLes contrôles réguliers de santé sont-ils importants ?\nL'hydratation joue-t-elle un rôle dans la santé des apolipoprotéines ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Propylthiouracil#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Apolipoprotéines",
"description": "Quels traitements existent pour les anomalies d'apolipoprotéines ?\nLes médicaments peuvent-ils normaliser les apolipoprotéines ?\nLe régime alimentaire influence-t-il les apolipoprotéines ?\nLes exercices physiques affectent-ils les niveaux d'apolipoprotéines ?\nLes traitements naturels peuvent-ils aider les apolipoprotéines ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Propylthiouracil#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Apolipoprotéines",
"description": "Quelles complications peuvent survenir avec des apolipoprotéines anormales ?\nLes apolipoprotéines anormales peuvent-elles causer des diabètes ?\nLes troubles hépatiques sont-ils liés aux apolipoprotéines ?\nLes apolipoprotéines affectent-elles la santé rénale ?\nLes apolipoprotéines peuvent-elles influencer l'inflammation ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Propylthiouracil#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Apolipoprotéines",
"description": "Quels sont les principaux facteurs de risque pour les anomalies d'apolipoprotéines ?\nL'hérédité joue-t-elle un rôle dans les anomalies d'apolipoprotéines ?\nLe vieillissement influence-t-il les niveaux d'apolipoprotéines ?\nLe sexe a-t-il un impact sur les apolipoprotéines ?\nLe mode de vie sédentaire est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D001053?mesh_terms=Propylthiouracil#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie des apolipoprotéines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant les niveaux d'apolipoprotéines sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les apolipoprotéines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages des apolipoprotéines A1 et B sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines sont-elles liées aux maladies cardiovasculaires ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux d'apolipoprotéines sont associés à un risque accru de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des apolipoprotéines par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la détection se fait principalement par des analyses sanguines, pas par imagerie."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème d'apolipoprotéines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'athérosclérose peuvent indiquer des anomalies d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à des niveaux élevés d'apolipoprotéines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés peuvent entraîner des douleurs thoraciques ou des crises cardiaques."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines affectent-elles le métabolisme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles jouent un rôle clé dans le métabolisme lipidique et peuvent causer des troubles."
}
},
{
"@type": "Question",
"name": "Comment les apolipoprotéines influencent-elles le cholestérol ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles transportent le cholestérol dans le sang, influençant les niveaux de cholestérol total."
}
},
{
"@type": "Question",
"name": "Des symptômes neurologiques peuvent-ils être liés aux apolipoprotéines ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent être associées à des troubles neurologiques comme l'AVC."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines sont-elles liées à l'obésité ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux peuvent être observés chez les personnes obèses."
}
},
{
"@type": "Question",
"name": "Comment prévenir les anomalies d'apolipoprotéines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain avec une alimentation équilibrée et de l'exercice régulier."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les apolipoprotéines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter le risque d'anomalies d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les apolipoprotéines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter les niveaux d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Les contrôles réguliers de santé sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans de santé réguliers aident à détecter les anomalies tôt."
}
},
{
"@type": "Question",
"name": "L'hydratation joue-t-elle un rôle dans la santé des apolipoprotéines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation est essentielle pour le métabolisme lipidique."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les anomalies d'apolipoprotéines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les statines et les changements de mode de vie sont souvent recommandés."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils normaliser les apolipoprotéines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent aider à réguler les niveaux d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Le régime alimentaire influence-t-il les apolipoprotéines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un régime riche en fibres et faible en graisses saturées peut aider."
}
},
{
"@type": "Question",
"name": "Les exercices physiques affectent-ils les niveaux d'apolipoprotéines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer les niveaux d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Les traitements naturels peuvent-ils aider les apolipoprotéines ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes et suppléments peuvent soutenir la santé lipidique, mais consultez un médecin."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des apolipoprotéines anormales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maladies cardiovasculaires, des AVC et des troubles métaboliques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines anormales peuvent-elles causer des diabètes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont liées à un risque accru de diabète de type 2."
}
},
{
"@type": "Question",
"name": "Les troubles hépatiques sont-ils liés aux apolipoprotéines ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux peuvent être associés à des maladies hépatiques."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines affectent-elles la santé rénale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies peuvent contribuer à des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Les apolipoprotéines peuvent-elles influencer l'inflammation ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés sont souvent associés à des états inflammatoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les anomalies d'apolipoprotéines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme, une mauvaise alimentation et le manque d'exercice sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans les anomalies d'apolipoprotéines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies cardiovasculaires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le vieillissement influence-t-il les niveaux d'apolipoprotéines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner des modifications des niveaux d'apolipoprotéines."
}
},
{
"@type": "Question",
"name": "Le sexe a-t-il un impact sur les apolipoprotéines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des différences hormonales peuvent influencer les niveaux d'apolipoprotéines entre les sexes."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire augmente le risque d'anomalies d'apolipoprotéines."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Institut de Recerca Sant Pau, 08041 Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain.
Publications dans "Apolipoprotéines" :
3 publications dans cette catégorie
Affiliations :
Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Department of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Department of Medicine, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada.
Publications dans "Apolipoprotéines" :
3 publications dans cette catégorie
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Laboratoire du Métabolisme Moléculaire des Lipides, Université du Québec à Montréal, Département des Sciences Biologiques, Case Postale 8888, Succursale Centre-ville, Montréal, QC H3C 3P8, Canada.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
Mental Health and Society Division, Douglas Mental Health University Institute, Montreal, QC, Canada.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Institute of Mental Health, Hebei Mental Health Centre, Hebei, China.
Department of Sleep Medicine, Hebei Psychiatric Hospital, Hebei, China.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Institute of Mental Health, Hebei Mental Health Centre, Hebei, China. yunshucoffee@sina.com.
Department of Sleep Medicine, Hebei Psychiatric Hospital, Hebei, China. yunshucoffee@sina.com.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, 16 Lin Cui Road, Beijing, 100101, China. zhangxy@psych.ac.cn.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology University of Kansas Medical Center, Kansas City, KS 66160, USA.
University of Kansas Alzheimer's Disease Center, Kansas City, KS 66160, USA.
Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Department of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology & Pharmacology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada; Robarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, Canada. Electronic address: mlk@robarts.ca.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
School of Public Health, Guangdong Medical University, Zhanjiang, 524023, China.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Public Health Foundation India, Gurugram, Haryana, India; Centre for Chronic Disease Control, New Delhi, India; London School of Hygiene & Tropical Medicine, United Kingdom. Electronic address: dprabhakaran@ccdcindia.org.
Publications dans "Apolipoprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Hebei Medical University, Shijiazhuang, People's Republic of China.
Department of Endocrinology, Hebei General Hospital, Shijiazhuang, People's Republic of China.
Publications dans "Apolipoprotéines" :
1 publication dans cette catégorie
Affiliations :
Center for Biomedical Research (CEBIOR), Faculty of Medicine, Universitas Diponegoro, Semarang 50275, Central Java, Indonesia.
Publications dans "Apolipoprotéines" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
Publications dans "Apolipoprotéines" :
1 publication dans cette catégorie
Affiliations :
Department of Psychology, University of Marlyand, College Park, MD 20742, USA.
MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Publications dans "Apolipoprotéines" :
1 publication dans cette catégorie
Affiliations :
MIND Institute, University of California Davis Medical Center, Sacramento, CA 95817, USA.
Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
Publications dans "Apolipoprotéines" :
1 publication dans cette catégorie
Affiliations :
Division of Biostatistics, School of Medicine, University of California Davis, Davis, CA 95616, USA.
Publications dans "Apolipoprotéines" :
The most common cause of hyperthyroidism is Graves' disease. Propylthiouracil (PTU) is one of the drugs used to treat this disease. Leukocytoclastic vasculitis is described among dermatologic adverse ...
A 18-year-old woman, allergic to methimazole, developed a vasculitis associated to ANCAs with characteristics of leukocytoclastic vasculitis, associated to PTU treatment. She did not present systemic ...
Leukocytoclastic vasculitis should be considered in the spectrum of complications caused by the consumption of propylthiouracil. The lesions can manifest over time, from a few weeks to years after tak...
Drug reaction with eosinophilia and systemic symptoms (DRESS), also known as Drug-induced hypersensitivity syndrome (DiHS), is a severe adverse drug reaction. Propylthiouracil, a member of thiouracils...
A 38-year-old female was treated with methimazole for hyperthyroidism at first. 4 weeks later, the patient developed elevated liver transaminase so methimazole was stopped. After liver function improv...
Propylthiouracil is a rare cause of the DRESS/DiHS syndrome, which typically consists of severe dermatitis and various degrees of internal organ involvement. We want to emphasize through this severe c...
Thyroid storm is the most severe form of thyrotoxicosis, with high mortality, and is treated with propylthiouracil and methimazole. Some guidelines recommend propylthiouracil over methimazole, althoug...
To compare outcomes associated with use of propylthiouracil vs methimazole for the treatment of thyroid storm....
This comparative effectiveness study comprised a large, multicenter, US-based cohort from the Premier Healthcare Database between January 1, 2016, and December 31, 2020. It included 1383 adult patient...
Patients received either propylthiouracil or methimazole for treatment of thyroid storm. Exposure was assigned based on the initial thionamide administered....
The primary outcome was the adjusted risk difference of in-hospital death or discharge to hospice between patients treated with propylthiouracil and those treated with methimazole, assessed by targete...
A total of 1383 patients (656 [47.4%] treated with propylthiouracil; mean [SD] age, 45 [16] years; 473 women [72.1%]; and 727 [52.6%] treated with methimazole; mean [SD] age, 45 [16] years; 520 women ...
In this comparative effectiveness study of a multicenter cohort of adult patients with thyroid storm, no significant differences were found in mortality or adverse events in patients who were treated ...
A 71-year-old man with hyperthyroidism complained of headache lasting two months. He had been using propylthiouracil (PTU) for 14 years. Treatment intensification did not improve the symptoms. Blood t...
The purpose of this meta-analysis was to assess the safety of the anti-thyroid drugs (ATDs) propylthiouracil (PTU) and methimazole (MMI) in the treatment of hyperthyroidism during pregnancy....
From inception until June 2, 2022, all available studies were searched in PubMed, Web of Science, Cochrane, EBSCO, Embase, Scopus, and CNKI....
Thirteen articles satisfying the inclusion criteria were examined. Our meta-analysis indicated that pregnant women treated with MMI had a higher risk of congenital anomalies than those treated with PT...
The study confirmed propylthiouracil is a safer alternative to methimazole for treating hyperthyroidism in pregnant women, and it is appropriate to treat maternal thyroid disease with PTU during the f...
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is an autoimmune condition characterized by necrotizing inflammation of small vessels throughout the body. Pharmaceutical agents have ...
The use of propylthiouracil (PTU) is associated with the development of autoantibodies, namely, antineutrophil cytoplasmic antibodies (ANCAs), which are associated with the pathogenesis of ANCA-associ...
We present a case of neonatal goiter caused by exposure to propylthiouracil (PTU) during pregnancy in this case report. The mother was treated with PTU while pregnant and had a history of Graves' illn...
Hyperthyroidism is more common in women and the sensitivity of thyroid function changes during pregnancy. Excess levels of thyroid hormones and thioamides have a major impact on maternal and fetal out...
Agranulocytosis is a serious adverse effect of methimazole (MMI) and propylthiouracil (PTU), and although there have been reports suggesting a dose-dependent incidence in relation to both drugs, the e...